Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Zoetis Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Zoetis şirketinin toplam hissedar öz sermayesi $5.0B ve toplam borcu $6.6B olup, bu da borç-öz sermaye oranını 132.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $14.2B ve $9.2B dir. Zoetis 'in FAVÖK'ü $3.2B faiz karşılama oranı 24.7 dur. Şirketin $1.6B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

132.9%

Borç/özkaynak oranı

US$6.59b

Borç

Faiz karşılama oranı24.7x
NakitUS$1.57b
EşitlikUS$4.96b
Toplam yükümlülüklerUS$9.21b
Toplam varlıklarUS$14.17b

Son finansal sağlık güncellemeleri

Recent updates

Zoetis: Investing In Pet Health And Portfolio Wealth

Sep 26

Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

Sep 20
Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?

There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Aug 30
There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price

Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target

Aug 13

Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)

Aug 07

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Jul 16
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price

Jul 03

Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader

Jun 11

A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Jun 10
A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

May 23
Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth

Zoetis: Why The Focus On Companion Animal Segment Will Pay Off

May 22

The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

May 04
The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Zoetis: Long-Term Buy Despite Safety Concerns

May 03

Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment

Apr 15

Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Apr 12
Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit

Zoetis: My Favorite Healthcare Stock Right Now

Mar 21

Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Mar 03
Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness

Feb 27

Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns

Jan 10

Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Jan 01
Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Dec 06
Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?

Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Nov 18
Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today

Zoetis: High-Quality Compounder With A Reasonable Price After Earnings

Nov 09

Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now

Oct 26

Zoetis Is An Impressive Healthcare Compounder

Sep 26

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Sep 25
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Sep 04
Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly

Zoetis: Pawses Pain, Librela OA Treatment Targets Furry Friends In The U.S.

Aug 22

Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Aug 12
Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?

Zoetis: My Dog Approves Of This Dividend Compounder

Jul 19

Zoetis: A Purrfect Addition To Your Portfolio

Jun 22

Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

Jun 10
Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?

These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Apr 16
These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Mar 10
Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)

Zoetis rises on 2023 revenue forecast above estimates, Q4 profit in-line with consensus

Feb 14

Zoetis Is An Awesome Dividend Growth Stock

Jan 17

It's A Great Time To Buy Zoetis Shares

Jan 10

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Jan 03
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Dec 29
Is Zoetis (NYSE:ZTS) Using Too Much Debt?

Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ZTS 'nin kısa vadeli varlıkları ( $6.2B ) kısa vadeli yükümlülüklerini ( $1.8B ) aşıyor.

Uzun Vadeli Yükümlülükler: ZTS 'un kısa vadeli varlıkları ( $6.2B ) uzun vadeli yükümlülüklerini ( $7.4B ) karşılamamaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ZTS 'nin net borç/öz sermaye oranı ( 101.2% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: ZTS 'nin borç/öz sermaye oranı son 5 yılda 267.4% seviyesinden 132.9% seviyesine düştü.

Borç Kapsamı: ZTS 'nin borcu işletme nakit akışı ( 41.2% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: ZTS 'in borcuna ilişkin faiz ödemeleri EBIT ( 24.7 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin